title: Hepatitis B therapy, hepatocellular carcinoma and HBsAg mutants.
authors: Alfredo
authors: A
authors: Marzano
authors: Andrea
authors: A
authors: Marengo
authors: Ezio
authors: E
authors: David
authors: Mario
authors: M
authors: Rizzetto
mesh_terms: D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology / Q000601:surgery; D004279:DNA, Viral / Q000097:blood; D004359:Drug Therapy, Combination; D006509:Hepatitis B / Q000097:blood / Q000188:drug therapy*; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006801:Humans; D007150:Immunohistochemistry; D019259:Lamivudine / Q000009:adverse effects / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D063065:Organophosphonates / Q000009:adverse effects / Q000627:therapeutic use; D060888:Real-Time Polymerase Chain Reaction; D014057:Tomography, X-Ray Computed
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens; D063065:Organophosphonates; D019259:Lamivudine; C053001:adefovir; D000225:Adenine